Nontuberculous mycobacteria strains isolated from patients between 2013 and 2017 in Poland. Our data with respect to the global trends by Kwiatkowska, Sylwia et al.
ORIGINAL RESEARCH
291www.journals.viamedica.pl
Address for correspondence: Sylwia Kwiatkowska Clinical Pneumonology Ward, Medical University od Łódź, Kopcińskiego 22, 90–153 Łódź, e-mail: s_kwiat@wp.pl
DOI: 10.5603/ARM.a2018.0047
Received: 05.10.2018
Copyright © 2018 PTChP
ISSN 2451–4934
Sylwia Kwiatkowska1, Ewa Augustynowicz-Kopeć2, Maria Korzeniewska-Koseła3, Dorota Filipczak2, 
Paweł Gruszczyński4, Anna Zabost4, Magdalena Klatt2, Małgorzata Sadkowska-Todys5
1Clinical Pneumology Ward, Medical University od Łódź, Poland
2National Tuberculosis Reference Laboratory, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
3Department of Tuberculosis Epidemiology and Surveillance, National Tuberculosis and Lung Diseases Research Institute, Warsaw, 
Poland
4Wielkopolska Centre of Pulmonology and Thoracic Surgery in Poznan, Poland
5Department of Epidemiology, National Institute of Public Health — National Institute of Hygiene, Warsaw, Poland
Nontuberculous mycobacteria strains isolated from patients 
between 2013 and 2017 in Poland. Our data with respect  
to the global trends
The authors declare no financial disclosure
Abstract
Introduction: During the last decades the prevalence of NTM infections has increased, especially in developed countries. The aim 
of the study was to provide an overview on all NTM isolated from clinical samples in Poland between 2013 and 2017. 
Material and methods: The study comprised 2799 clinical specimens, mostly respiratory accessed in the reference laboratory 
of National Tuberculosis and Lung Diseases Research Institute in Warsaw and in the Wielkopolska Center of Pulmonology and 
Thoracic Surgery, Poland, 2013–2017. 
Results: During the study period 35 species of NTM were isolated . The number of isolates increased almost 1.6-fold: from 420 
in 2013 to 674 in 2017. M. kansasii, M. avium, M. xenopi, M. gordonae and M. intracellulare were the most common species. 
This NTM pattern was rather stable over the time. If the aggregated amount of all MAC species was taken into account they 
dominated over M. kansasii from 2015. M. avium and M. intracellulare were more often isolated from women, while M. kansasii, 
M. gordonae and M. xenopi predominated in men. Men and women were infected almost with the same frequency. In older 
patients 65+ women were in majority, quite opposite to those aged 25 to 64 years. 
Conclusion: In Poland, like in other countries increased frequency of isolated NTM. M. kansasii and M. avium were the most 
frequently identified species from clinical samples. Men and women were infected with NTM with the same frequency.
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Introduction
An increased isolation as well as the preva-
lence of nontuberculous mycobacteria (NTM) 
diseases has been noticed during the last decades 
[1, 2]. In the US, the prevalence of nontuberculous 
mycobacterial lung disease was calculated at 47 
cases per 100,000 population in 2007, with an 
annual increase of 8.2% per year from 1997 to 
2007 [2]. Interestingly, high geographic variability 
was noticed: the highest prevalence in Hawaii 
(396/100,000) and the lowest in some Midwestern 
states (< 50/100,000). Moreover, the prevalence 
varied by ethnicity, with the highest rate in Paci-
fic and Asian Islanders and the lowest in blacks. 
However, opposite to tuberculosis (TB), NTM 
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diseases are not reportable conditions in many 
countries worldwide. Thus, epidemiological data 
are usually incomplete or even unknown.
NTMs or mycobacteria other than tuberculo-
sis (MOTT) are diverse environmental organisms 
widespread in water and soil. Up to now more 
than 150 NTM species have been identified [3, 4]. 
NTM have a broad spectrum of virulence, about 
20 has a known pathogenicity. These pathogens 
may cause lung disease, the most common com-
plication, less frequently lymphadenitis, skin, soft 
tissue infections, and disseminated disease. The 
most widespread species causing lung infection 
are the slow-growing (SGM): M. avium complex 
(MAC; consisting of M. avium, M. intracellulare 
and M. chimaera), M. kansasii, M. malmoense, 
M. xenopi and the rapid-growing (RGM): M. ab-
scessus, M. chelonae and M. fortuitum [5]. The 
new phenomenon is the increase of NTM infec-
tions not only in immunocompromised patients 
but also in ostensibly immunocompetent popu-
lation. Some NTM strains have evolved over the 
years, while the new ones have emerged. Also, the 
patterns of the most common NTM strains differ 
between the regions of the world. 
In Poland, there are two laboratories that 
identify the species of NTM: the laboratory in 
the National Tuberculosis and Lung Diseases 
Research Institute in Warsaw, from which most 
of the results were sourced, and the laboratory 
in the Wielkopolska Centre of Pulmonology and 
Thoracic Surgery in Poznan. So the aim of our 
study was: 1) to provide an overview on the types 
of NTMs isolated from patients in Poland over 
the period 2013–2017, 2) to compare the present 
isolates with those from the past, 3) to assess our 
situation with respect to the global trends.
Material and methods
All, mostly respiratory (i.e. sputum and 
bronchoaspirate), clinical samples of patients 
culture positive for NTM, which were sent to 
the laboratory in Warsaw and to the laboratory in 
Poznan between 2013 and 2017 were included in 
the study. Detailed numbers of examined samples 
per year are presented in Table 1. 
The significance (Si) of the differences in 
proportions (distribution of species by sex) was 
assessed with chi-square test. P < 0.05 was re-
garded as statistically significant.
Processing of clinical samples
Clinical samples were processed in all la-
boratories according to the standard procedure. 
Briefly, clinical samples were digested and decon-
taminated by adding N-actetyl-L-cysteine-sodium 
hydroxide solution. Then, the mixture was natu-
ralized with buffered phosphate saline and centri-
fuged. Sediments of each sample were cultured in 
Lowenstein-Jensen and Stonebrink mediums, as 
well as in liquid Middlebrook, medium of Bactec 
MGIT 960 system (Becton-Dickinson-BD), accor-
ding to previously described method [6]. 
Then, using TBc ID MGIT (TBc ID, Becton 
Dickinson, Sparks, MD) test, mycobacteria were 
assigned to Mycobacterium tuberculosis complex 
(MTC) group or to NTM.
For identification of NTM species GenoTy-
pe Mycobacterium CM ver. 1.0 and 2.0 (Hain, 
Lifescience, Nehren, Germany) was performed 
according to the manufacturer’ instructions [4]. 
This test can identify fourteen most common 
NTMs as well as MTC, Mycobacterium abscessus 
complex (MABC) and MAC. Detailed specification 
was performed using GenoType MTBC (for MTC 
specis), GenoType NTM-DR (for MABC and MAC 
species) and GenoType Mycobacterium AS assay 
for identification of the rest infrequent mycobac-
teria [7–9].
The study was approved by the Ethic Com-
mittee of the National Tuberculosis and Lung Di-
seases Research Institute — approval no. 9/2015.
Results
A total of 2799 specimens were included in 
the study. 1438 clinical samples belonged to men 
and 1361 to women. Overall, thirty five NTM 
species were isolated from the clinical specimens 
during five years. The number of NTM increased 
from 420 in 2013 to 674 in 2017 (Table 1). M. 
kansasii, M. avium, M. xenopi, M. gordonae and 
M. intracellulare were identified the most frequently. 
These five species accounted for 85.8% of all 
examined specimens in the study period (range 
from 84.7% (2015 and 2016) to 87.0% (2014)). The 
rest of isolates, except M. fortuitum were observed 
very infrequently.
The order of all the most common species 
was almost stable during the study, changing in 
2015–2017, where isolates of M. xenopi outnum-
bered isolates of M. gordonae and in 2016, in 
which M. avium dominated instead of M. kansasii 
(Fig. 1, Table 2).
If the aggregated amount of all MAC species 
is given, since 2015 they have dominated over 
M. kansasii (in 2013 — MAC 108, M. kansasii 
134; in 2014–130 vs. 166; in 2015–185 vs. 155; 
2016–167 vs. 129; 2017–213 vs. 177).
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Table 1. Nontuberculous mycobacteria (NTM) species isolated from clinical samples in Poland, between 2013 and 2017
NTM species 2013 2014 2015 2016 2017 Total
M. abscessus 2 4 6 11 8 31
M. aurum 0 0 1 0 0 1
M. avium 89 99 149 134 145 616
M. celatum 0 4 1 1 1 7
M. chelonae 2 3 5 5 5 20
M. chimaera 0 0 0 2 12 14
M. flavescens 3 0 0 2 0 5
M. fortuitum 24 27 52 28 35 166
M. genavense 0 0 0 2 1 3
M. gordonae 66 82 70 92 96 406
M. heckeshornense 0 0 1 1 2 4
M. interjectum 1 0 0 2 0 3
M. intracellulare 19 31 36 31 56 173
M. kansasii 134 166 155 129 177 761
M. lentiflavum 0 2 1 2 5 10
M. mageritense 8 0 0 0 2 10
M. malmoense 0 9 5 7 0 21
M. marinum 1 1 2 0 0 4
M. monacense 0 0 0 0 2 2
M. mucogenicum 2 8 6 12 7 35
M. neoaurum 0 0 5 1 0 6
M. nonchromogenicum 4 0 1 1 0 6
M. novocastrense 0 0 0 0 1 1
M. parafortuitum 0 0 1 0 0 1
M. parascrofulaceum 0 0 0 1 0 1
M. peregrinum 5 3 2 2 5 17
M. scrofulaceum 0 1 2 0 1 4
M. simiae 2 0 0 1 0 3
M. shimoidei 0 0 1 0 1 2
M. smegmatis 0 0 0 1 0 1
M. szulgai 0 5 1 3 3 12
M. tokaiense 0 0 0 2 0 2
M. triviale 1 0 0 1 0 2
M. ulcerans 0 0 0 0 1 1
M. xenopi 57 74 106 103 108 448
Total 420 519 609 577 674 2799
There were only few species which had not 
been isolated before 2017 like M. monacense, 
M. novocastrense and M. ulcerans.
NTM species distribution was only slightly 
higher in men than in women (p > 0.05) (Fig. 2, 
Table 3).
Advances in Respiratory Medicine 2018, vol. 86, no. 6, pages 291–298 
294 www.journals.viamedica.pl
Table 2. Number of the most common nontuberculous mycobacteria (NTM) species in Poland, 2013–2017
NTM species M. kansasii M. avium M. xenopi M. gordonae M. intracellulare
2013 134 89 57 66 19
2014 166 99 74 82 31
2015 155 149 106 70 36
2016 129 134 103 92 31
2017 177 145 108 96 56
Total 761 616 448 406 173
Figure 1. Distribution of the most common nontuberculous mycobacteria (NTM) species by year, 2013–2017
Figure 2. Nontuberculous mycobacteria (NTM) species distribution by sex in Poland, 2013–2017
Distribution of NTM isolates by sex and age 
was available in 2017 only.
Except for the youngest groups: 0–14 year
-old and 15–24 year-old men predominated, 
but among those > 65 year-old women were in 
majority (Fig. 3).
Two species: M. avium (359 vs. 257), M. in-
tracellulare (99 vs. 74) were more often isolated 
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Table 3. Distribution of nontuberculous mycobacteria (NTM) 
species by sex and number in Poland, 2013–2017
Year Female Male Total
2013 207 213 420
2014 247 272 519
2015 292 317 609
2016 282 295 577
2017 333 341 674
Figure 3. Distribution of NTM isolates in female and male according to the age groups in 2017
Figure 4. Distribution of most common nontuberculous mycobacteria 
(NTM) species by sex in Poland, 2013–2017; *p < 0.001
from women, while M. kansasii, M. gordonae 
and M. xenopi predominated in men (393 vs. 
368; 223 vs 183, and 274 vs. 174, respecti-
vely). Only the differences according M. avium 
and M. xenopi were statistically significant 
(p < 0.0001) (Fig. 4).
Discussion
Our investigation is a laboratory-based study 
in which the large number of NTM strains iso-
lated from clinical samples have been assessed. 
We did not provide any data about clinical re-
levance of isolated strains. It is known that NTM 
can cause progressive lung disease or can reside 
within the lungs representing colonization. It can 
be assumed that doctors then asked for species 
identification, if they suspected a disease. On 
the other hand, in Poland, there is a statutory 
obligation to report cases of mycobacteriosis 
and growth of NTM. According to the National 
Institute of Public Health — National Institute 
of Hygiene, having available aggregated data, 
a total of 1114 cases of mycobacteriosis were 
registered in the years 2013–2017 [10]. By our 
study, the number of patients yielding NTM iso-
lates from the respiratory tract increased 1.6-fold 
between 2013 and 2017, from 420 to 674. Also, 
high NTM species diversity was found. Over the 
study period 35 species were isolated from clini-
cal specimens. The most common species were 
M. kansasii, M. avium, M. xenopi, M. gordonae 
and M. intracellulare. 
The first study trying to analyze NTM in 
pulmonary specimens in our country was con-
ducted by Janowiec et al. [11] at the beginning of 
the 1970’s. They found that 3.98% out of 106,182 
culture-positive specimens isolated from patients 
registered in pulmonary clinics between 1971 
and 1974 were NTM. As in that time NTM were 
classified according to Ruynion — most of them 
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— 68.1% belonged to rapidly growing mycobac-
teria (RGM), followed by the species from the III 
(15.9%) and the II group (13%).The situation was 
quite opposite to that in the present study, where 
slowly growing mycobacteria (SGM) were predo-
minated. Twenty years later Słupek and coworkers 
[12] basing on similar material demonstrated that 
1% (267) of all culture — positive specimens were 
NTM. However, in that study only 57% of isolated 
mycobacteria were identified as species. Inte-
restingly, like nowadays, M.kansasii, MAC and 
M. xenopi were the most common species [12]. 
Of note, 77% of NTM were associated with pul-
monary mycobacteriosis (the diagnosis did not 
have to meet the criteria currently recommended).
According to current results, in Poland NTM 
were isolated only slightly more often in men than 
in women. Similar epidemiological situation, 
but with greater men predominance (61.8%), 
was reported in the previous century [11]. Ho-
wever, we found also that in older group > 65 
year-old women predominated. In our study, M. 
avium and M. intracellulare were found in more 
women than men; M. kansasii, M. gordonae and 
M. xenopi — in men. In line with the data reported 
from other countries, the number of isolated NTM 
increased with the population’s age, i.e.: 15–24 yr 
— 12 isolates, 25–34 yr — 50 isolates to 316 in 
those older than 65. 
Similar trend was reported also in other co-
untries in our region [13–15]. In England, Wales 
and Northern Ireland, the number of examined 
NTM specimens rose from 459 in 1995 to 1608 in 
2006 [13]. Moreover, like in our study men gained 
predominance (60%). Nevertheless, in some set-
tings situation is reversed (2,16). The recent study 
from Japan revealed that NTMs were isolated 
mainly from individuals older than 70 years of 
age, mainly women (65.5%) [16]. Also in the US, 
the majority of subjects tended to be women in 
older age like in Lady Windermere syndrome [17]. 
It should be stressed that all authors agreed that 
patients with NTM infection were older than those 
with tuberculosis and were usually 60+. Compa-
rable NTM pattern to our current results was also 
observed in the retrospective study conducted in 
Bordeaux, France over 12years (2002–2013) [18]. 
However, such stable trend among mycobacterial 
species over the years is not a typical phenome-
non. Santin et al. [19] studying NTM infection in 
Barcelona region between 1994 and 2014 revealed 
that M. kansasii was the most common in the first 
half of the period, while MAC in the second one.
Looking on global geographical distribution 
of different NTM species, high diversity can be 
seen. However, some trends across the regions 
are noticed. In North America, in Ontario, Ca-
nada, the most common are: MAC, followed by 
M. xenopi and RGM [20], while in the US — MAC, 
M. abscessus/M. chelonae and M. xenopi domina-
te [17]. Few recent studies from South America 
have revealed that MAC is generally the most 
common there, and M. kansasii is also frequent 
[17–21]. Similarly, MAC is predominant in South 
Asia and in Queensland, Australia, whereas MAC 
with M. fortuitum and simiae in the Middle East 
[22, 23]. 
In the European Union, data provided by the 
NTM — Network European Trials Group in 2008 
revealed that MAC (47%), M. gordonae (11%), 
M. xenopi (8%), M. fortuitum (7%) and M. kansasii 
(4%) were the most frequently identified [24]. 
However, there are still substantial differences 
between south and north regions. Although 
MAC was isolated with the highest frequency in 
northern and southern Europe (44% vs. 31%), 
M. xenopi was more prevalent in southern Europe 
(21% vs. 6%), in contrast to M. bohemicum, which 
was almost exclusively isolated in northern Eu-
rope. M. kansasii, common in Poland but losing 
its dominance over MAC as a whole, predomina-
ted in Slovakia, while M. xenopi was especially 
frequent in Hungary [24]. High prevalence of 
M. kansasii in eastern Europe, South America 
as well as in metropolitan centers of London, 
Paris and Johannesburg is probably related to the 
mining activities [25]. Moreover, the study from 
Queensland (Australia) found that increased soil 
bulk density positively correlated with M. kansa-
sii disease [26]. Likewise in Poland, where in the 
previous century M. kansasii dominated in mine 
regions [11], but nowadays this species is more 
typical of urban areas. 
In this context, very interesting issue are 
the species-specific environmental niches with 
subsequent transmission to humans. Neverthe-
less, only scarce published data dealt with this 
problem. Of note, it should be stressed that there 
is no simple association between environmental 
NTMs and those revealed in clinical samples. 
Velayati et al. [27] studying water and soil from 
suburbian areas of Tehran and clinical samples of 
patients living there demonstrated that M. farci-
nogenes and M. fortuitum were the most common 
environmental inhabitants, while M. simiae and 
M. chelonae the most frequent species isolated 
form patients. There are some explanations of the-
se discrepancies. Firstly, abilities of NTM species 
to cause the disease in humans differ. Secondly, 
the development of infection or mycobacteriosis 
Sylwia Kwiatkowska et al., Increased NTM infections in Poland
297www.journals.viamedica.pl
depends on host risk factors like co-morbidities 
(GERD, COPD, bronchiectases), taken drugs (im-
munosuppressive, immunomodulatory), low BMI 
or thoracic skeletal deformation. Surprisingly, 
more and more often idiopathic mycobacteriosis 
with no predisposing conditions occur. Such si-
tuation takes place in the US among older women 
who suffer from mycobacteriosis even more often 
than men with COPD [28]. Unfortunately, there 
are no such data from our country.
Such chronic conditions like mycobacterial 
infections, sometimes even lifelong can be better 
characterized by the prevalence than the inciden-
ce. However, we could not provide data about the 
prevalence of NTM infection in Poland because 
the later history of the patients in whom NTMs 
have been detected and identified is not known. 
Looking on the data from high-income countries 
worldwide, such a tendency can be seen: as the 
prevalence and incidence of tuberculosis are 
decreasing, the prevalence of NTM infections as 
well as mycobacteriosis increases [29, 30].
In conclusion, as in the 20th century M. tu-
berculosis was considered a global threat, in the 
21st century — an era of End TB, as was announ-
ced by the WHO, NTM infections are becoming 
a discernible problem. Although NTMs are not 
transmissible organisms among humans, with 
very rare exceptions, taking into account ageing 
of the European population and its increased 
comorbid conditions, this problem in our region 
will be greater than in developing countries.
In Poland, M. kansasii and M. avium were 
the most frequently identified NTM species from 
clinical samples. As in many other countries, the-
re were more samples taken from men, however, 
in those 65+ women dominated. M. avium and 
M. intracellulare were more often isolated from 
women, while M. kansasii and M. xenopi predo-
minated in men. 
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